Scientific Advisory Board

The Scientific Advisory Board (SAB) was created to provide Nuvo's management with scientific, medical and strategic advice on drug development plans and specific issues relating to its business. Nuvo's SAB currently consists of Dr. Stefan Meuer, a German immunologist who is chairman of the International Committee of the Federation of Clinical Immunology Societies; Dr. Lee Simon, an American rheumatologist and Harvard Associate Professor, who previously was a Director at the United States Food and Drug Administration, Dr. Rolf Zinkernagel, a Swiss Nobel prize-winning immunologist and Dr. Jonathan Wilkin, a former Director of the FDAs Dermatology and Dental Products Department.

• Dr. Stefan Meuer, MD
  Director, Institute of Immunology, University of Heidelberg Chairman, International Committee of the Federation of Clinical Immunology Societies
  Dr. Meuer is currently a director of the Institute of Immunology at the University Hospital in Heidelberg, Germany. He has a long and distinguished career in medical research and has authored/co-authored over 150 publications in the field of immunology. Dr. Meuer is a member of the German Scientific Council Committee, Medicine, Evaluation and Quantification, chairman of the board, Bio-Region Rhein Neckar and chairman, International Committee of the Federation of Clinical Immunology Societies. He received his M.D. from Johannes-Gutenberg-Universitat in Mainz, Germany.
• Dr. Lee S. Simon, MD
  Former Division Director, Analgesic, Anti Inflammatory, & Ophthalmologic Drug Product Division, CDER, FDA and Former Harvard Associate Professor of Medicine
  Dr. Simon is currently an Associate Clinical Professor at Harvard Medical School and head regulatory consultant with MEDACorp, management consulting group that offers strategic advice to leading life sciences and healthcare companies. Previously, Dr. Simon was with the FDA where he was the Division Director of the Arthritis, Analgesic and Ophthalmologic Drug Product Division.. Prior to his tenure at the FDA, Dr. Simon was Director of Rheumatology Clinical Research and as Associate Chief of Medicine at Beth Israel Deaconess Medical Center in Boston, MA. Dr. Simon attended Loyola College and received his medical degree from the University of Maryland School of Medicine.
• Dr. Rolf Zinkernagel, MD, PhD
  Retired Prof. of Institute of Experimental Immunology, Zurich, Switzerland
  Nobel Laureate in Medicine, 1996
  Dr. Zinkernagel is recently retired professor, Department of Pathology at the University of Zurich and has been the co-head of the Institute of Experimental Immunology in Zurich, Switzerland since 1992. Dr. Zinkernagel is an internationally recognized immunologist who has received more than 25 awards for his work during the past two decades, including the 1996 Nobel Prize in Medicine for discoveries concerning the specificity of the cell mediated immune defense. He received a Ph.D. from the Australian National University and a medical degree from the University of Basel in Switzerland.
• Dr. Jonathan Wilkin, MD,
  Former Director of the FDAs Dermatology and Dental Products Division
  Dr. Jonathan Wilkin is a pharmaceutical industry consultant and recently retired founding director of the FDA's Dermatology and Dental Products Division (March 1994 - Oct 2005). Prior to joining the FDA, Dr. Wilkin served on FDA's Dermatologic Drugs Advisory Committee and was a Professor at The Ohio State University in the Departments of Medicine and Pharmacology, where he was the Director of the Dermatology Division. Currently, Dr. Wilkin serves on the American Academy of Dermatology's Ad Hoc Task Force on the Academy's Efforts with the FDA and the Environment and Drugs Committee; He is a Member of the Board of the National Rosacea Society, and Chair of the Medical Advisory Board of the National Rosacea Society; he is a diplomate of both the American Board of Clinical Pharmacology and the American Board of Dermatology.